| Name: | Mirtazapine EP Impurity C |
| Catalogue No. | VL206002 |
| CAS No. | 191546-96-0 |
| Molecular Formula | C17H17N3O |
| Molecular Weight | 279.34 |
| Status | In-stock |
| IUPAC Name | 3,4,10,14b-Tetrahydro-2-methyl-pyrazino[2,1-a]pyrido[2,3-c][2]benzazepin-1(2H)-one |
| Synonyms | Mirtazapine USP Related Compound C |
| Appearance | Off White Powder |
| Description | Mirtazapine EP Impurity C (CAS No: 191546-96-0) or Mirtazapine Lactam is an impurity present in mirtazapine which is a noradrenergic and specific serotonergic antidepressant and enhances neurotransmission resulting in increased levels of serotonin that is beneficial for the treatment of chronic breathlessness. |
| References | Al-Majed, Abdulrahman, et al. “Mirtazapine.” Profiles of Drug Substances, Excipients and Related Methodology, 2018, pp. 209–54, https://doi.org/10.1016/bs.podrm.2018.01.002. Lovell, Natasha, et al. “Use of Mirtazapine in Patients with Chronic Breathlessness: A Case Series.” Palliative Medicine, vol. 32, no. 9, July 2018, pp. 1518–21, https://doi.org/10.1177/0269216318787450. |
